Myelodysplastic Syndrome — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Myelodysplastic syndrome
Pancytopenia with macrocytosis, dysplastic neutrophils (pseudo-Pelger-Huët), hypercellular marrow with trilineage dysplasia, <5% blasts, ring sideroblasts, and complex karyotype is MDS. IPSS-R risk stratification guides management. Complex karyotype indicates high-risk disease. Treatment for high-risk MDS: hypomethylating agents (azacitidine) or allogeneic SCT if eligible.
Reference: WHO – 2022 – MDS Classification; ELN 2024